Oral Micronized Progesterone vs Prometrium: What to Do When One Fails

What "Oral Micronized Progesterone" and Prometrium Actually Are

They are the same drug. Prometrium is the FDA-approved brand-name capsule containing 100 mg or 200 mg of micronized progesterone suspended in peanut oil with gelatin. When a clinician writes a prescription for "oral micronized progesterone," they are prescribing the same molecule, either as Prometrium or as a compounded preparation from a 503A or 503B pharmacy.

The word "micronized" describes particle size. Progesterone is poorly absorbed in its crystalline form, so grinding it to particles smaller than 10 microns dramatically increases the surface area available for gut absorption. Both the brand and well-made compounded versions use this same micronization process.

Why Does the Distinction Matter at All?

The distinction matters because compounded micronized progesterone is not FDA-approved. Potency studies have found variation of 10-15% above or below labeled dose in some compounded preparations, which is enough to change clinical outcomes. If you feel your progesterone "isn't working," the first question is: are you taking the brand or a compounded version?

Peanut Oil and Allergen Risk

Prometrium capsules are suspended in peanut oil. Women with a documented peanut allergy should not take Prometrium and must use a compounded version in a different vehicle. This is not a minor footnote. An allergic reaction can look like a "medication failure" if it causes symptoms that are misattributed to progesterone intolerance.

How Your Hormonal Life Stage Changes Everything

Progesterone pharmacokinetics shift meaningfully across the reproductive lifespan, and a dose that works in one stage may be inadequate in another.

Reproductive Years and Perimenopause

During your reproductive years, your ovaries produce progesterone in the luteal phase, reaching serum levels of 15-30 ng/mL at peak. Oral micronized progesterone produces much lower serum levels than this because of extensive first-pass hepatic metabolism. A 200 mg oral dose generates a peak serum progesterone of roughly 2-8 ng/mL, well below luteal-phase levels.

In perimenopause, your own progesterone output is erratic. Cycles may be anovulatory, meaning no corpus luteum forms and endogenous progesterone drops to near-zero for that cycle. If you are on sequential HRT (progesterone for part of the month), an anovulatory perimenopausal cycle layered on top of exogenous progesterone can create confusing symptom patterns.

Postmenopause

After menopause, ovarian progesterone output is effectively zero. Exogenous progesterone is given entirely to protect the uterus from estrogen-driven endometrial proliferation, not to replace what the ovaries once made. The 2022 Menopause Society (NAMS) position statement endorses oral micronized progesterone as the preferred progestogen for postmenopausal HRT when a progestogen is needed, citing its favorable cardiovascular and breast profile compared to synthetic progestogens.

The PEPI trial, published in JAMA in 1995, was the first large randomized trial to demonstrate this. In 875 postmenopausal women followed for three years, those on conjugated equine estrogen plus oral micronized progesterone had significantly better HDL cholesterol preservation than those on conjugated equine estrogen plus medroxyprogesterone acetate (MPA). That HDL benefit has since influenced decades of HRT prescribing toward body-identical progesterone.

The Most Common Reasons Oral Micronized Progesterone "Fails"

When a patient says progesterone is not working, the causes almost always fall into five categories.

1. Dose Is Too Low for the Goal

The dose you need depends on what you are treating.

• Endometrial protection with continuous combined HRT: 100 mg nightly. This dose is supported by biopsy data showing adequate suppression of endometrial proliferation in postmenopausal women on standard estrogen doses.
• Endometrial protection with sequential HRT: 200 mg nightly for at least 12 days per cycle. Fewer than 12 days leaves the endometrium inadequately protected.
• Sleep and mood in perimenopause: Some women need 200-300 mg to achieve the sedative effect mediated by progesterone's neurosteroid metabolite allopregnanolone. The 100 mg dose may be insufficient for this purpose.
• Luteal-phase support in fertility cycles: 200-400 mg daily in divided doses, a different clinical context entirely.

If you are on 100 mg and your main complaint is insomnia or anxiety, your dose may simply be too low, regardless of whether you are on brand or compounded.

2. Timing and Food Interactions

Oral progesterone absorption increases substantially when taken with food, especially fatty food. A study measuring serum progesterone after a 200 mg dose found that taking it with a meal increased peak serum levels by approximately 3-fold compared to fasting. If you take your capsule on an empty stomach and your clinician based dosing on fed-state pharmacokinetics, you may be underexposed.

Take your progesterone at bedtime with a small fatty snack if you are not already doing so.

3. First-Pass Metabolism Variability

Progesterone is heavily metabolized by the liver on first pass. CYP3A4 is the primary enzyme involved. Women who take strong CYP3A4 inducers such as rifampin, carbamazepine, or St. John's Wort may metabolize progesterone faster than average, dropping serum levels. This is not rare in clinical practice and is frequently overlooked.

4. Compounded Product Potency Issues

As noted above, compounded preparations can vary in actual potency. If you switched from Prometrium to a compounded version and symptoms returned, this is a legitimate reason to switch back to the FDA-approved brand for a controlled comparison.

5. The Wrong Route for Your Uterus

Oral progesterone has good endometrial effect because the hepatic metabolism produces progesterone metabolites that act locally on the endometrium. Vaginal progesterone bypasses the liver entirely and achieves very high local uterine levels with low serum levels, a phenomenon called the "first uterine pass effect." This route difference matters if you are using vaginal progesterone and expecting systemic sedative or mood effects. You will not get them at standard vaginal doses.

Oral Micronized Progesterone vs Prometrium: A Direct Comparison

The table below organizes the clinically relevant differences between Prometrium (brand) and compounded oral micronized progesterone to help you and your clinician identify where a failure may originate.

| Feature | Prometrium (Brand) | Compounded Oral Micronized Progesterone | |---|---|---| | FDA approval | Yes | No | | Potency consistency | Tightly regulated ±5% | May vary ±10-15% | | Vehicle | Peanut oil, gelatin capsule | Varies by pharmacy (olive oil, sunflower, other) | | Available doses | 100 mg, 200 mg | Any dose compounded | | Cost with insurance | Often covered | Often not covered | | Peanut-allergy safe | No | Yes (if different vehicle) | | Custom dosing (e.g. 150 mg, 75 mg) | No | Yes | | Evidence base | Directly studied in PEPI and others | Inferred from brand data |

The key insight: if you need a non-standard dose (75 mg for sleep without sedation, or 150 mg continuous), compounded is the only option. If you need maximum potency reliability, Prometrium wins.

When to Switch: A Decision Framework by Life Stage

Perimenopausal Women (Irregular Cycles, Vasomotor Symptoms)

You are most likely being prescribed progesterone in one of three ways: sequentially to regulate bleeding, continuously to suppress periods, or as standalone "progesterone therapy" for sleep and vasomotor symptoms.

Switch from compounded to Prometrium if:

• Your breakthrough bleeding is unpredictable and a compounded dose change did not fix it.
• You have had an endometrial biopsy showing proliferative or complex endometrium despite being on progesterone.
• You cannot confirm the compounding pharmacy's third-party potency testing.

Switch from Prometrium to compounded if:

• You have a confirmed peanut allergy.
• You need a dose not available in 100 mg or 200 mg increments.
• You are experiencing GI side effects from the gelatin capsule excipients.

Postmenopausal Women (HRT for Menopause Symptoms)

The stakes for endometrial protection are high. Unopposed estrogen increases endometrial cancer risk by approximately 2-12 fold depending on duration of use. If your progesterone is failing to protect the endometrium, this is a medical urgency, not a minor symptom issue.

Signs of endometrial protection failure include any unexpected vaginal bleeding on continuous combined HRT after 6 months of use, or an endometrial stripe greater than 4 mm on ultrasound. These findings warrant an endometrial biopsy and a review of your progesterone regimen before you continue estrogen.

Women With PCOS

In PCOS, anovulation means no endogenous progesterone in many cycles. If you are not trying to conceive, cyclic progesterone (oral micronized progesterone 200 mg for 12-14 days every 1-3 months) is one strategy to prevent endometrial hyperplasia from unopposed estrogen exposure. ACOG Practice Bulletin 194 addresses this directly. Failure here usually means inadequate cycle length or dose, not a brand-versus-compounded issue.

Sex-Specific Side Effects and What They Tell You About Dose

Progesterone's neurosteroid metabolite allopregnanolone acts on GABA-A receptors in your brain, producing sedation, anxiolysis, and, in some women, dizziness or dysphoria. These effects are dose-dependent and more pronounced in women who are sensitive to GABA-ergic drugs (including alcohol and benzodiazepines).

Common side effects that suggest your dose is too high:

• Excessive daytime sedation the morning after a nighttime dose
• Dizziness or balance disturbance
• Depressed mood or emotional blunting (paradoxical in some women)
• Breast tenderness disproportionate to your estrogen dose

Common symptoms that suggest your dose is too low or your regimen is failing:

• Breakthrough bleeding before day 12 of sequential use
• Persistent insomnia despite nighttime dosing
• Hot flashes that do not respond to estrogen (progesterone alone may help vasomotor symptoms in some women who cannot take estrogen)
• Endometrial thickening on pelvic ultrasound

A woman who switches from 200 mg Prometrium to 200 mg compounded and then develops breakthrough bleeding at day 8 of her sequential phase has a classic picture of potency loss in the compounded product. Switching back to brand or requesting third-party potency documentation from the compounding pharmacy is the next step.

Pregnancy, Lactation, and Contraception

This section is mandatory reading if you are in the perimenopausal transition or using progesterone off-label.

Pregnancy

Progesterone is not a contraceptive. Oral micronized progesterone and Prometrium do not prevent ovulation at HRT doses and should not be used as birth control. Perimenopausal women can still conceive until 12 consecutive months of amenorrhea have passed (the clinical definition of menopause in women without a surgical history). You need reliable contraception if pregnancy is possible.

Prometrium's FDA labeling carries a historical Class D designation for first-trimester use based on older case reports of genital malformations in offspring of women who used progestogens early in pregnancy. The current scientific consensus has largely moved away from attributing congenital anomalies to progesterone specifically, and vaginal micronized progesterone is used extensively for luteal support in IVF and for prevention of preterm birth in women with short cervix. However, oral micronized progesterone for HRT is not indicated during pregnancy. If you discover you are pregnant while on Prometrium for HRT, stop it and contact your OB or reproductive endocrinologist immediately.

The ACOG Committee Opinion on Progesterone Supplementation addresses the clinical use of progesterone in obstetric contexts; this is a distinct indication with different dosing and routes than HRT.

Lactation

Progesterone transfers into breast milk in small amounts. The relative infant dose has not been precisely quantified for oral micronized progesterone at HRT doses. Breastfeeding in postpartum women is addressed separately from postmenopausal HRT. If you are postpartum and your clinician is considering progesterone-only therapy, the LactMed database should be consulted for current transfer data.

High-dose exogenous progesterone can suppress prolactin-mediated milk production, which is a concern in early lactation. This risk is lower with progestogen-only methods initiated after 6 weeks postpartum.

Contraception Requirement

If you are perimenopausal and on estrogen-progesterone HRT, the progesterone in your HRT regimen does not provide contraceptive protection. A separate contraceptive method is required. Options compatible with HRT include barrier methods, copper IUD, or the levonorgestrel IUD (which also provides the progestogen component of HRT in some protocols, reducing or eliminating the need for separate oral progesterone).

Who This Regimen Is Right For (and Who Should Look at Other Options)

Good Candidates for Oral Micronized Progesterone (Either Brand or Compounded)

• Postmenopausal women with a uterus who need endometrial protection on estrogen HRT
• Perimenopausal women seeking body-identical hormone therapy with a favorable breast and cardiovascular profile
• Women with a history of mood sensitivity to synthetic progestogens like MPA or norethindrone
• Women who want the sedative benefit of progesterone for sleep
• Women with PCOS who need cyclic progestogen to prevent endometrial hyperplasia

Women Who May Need a Different Approach

• Women with a confirmed peanut allergy: compounded progesterone in a safe vehicle, or vaginal micronized progesterone
• Women with severe first-pass metabolism issues or CYP3A4 drug interactions: vaginal progesterone avoids hepatic metabolism
• Women who cannot tolerate the sedative effect even at 100 mg: a lower compounded dose (50-75 mg) or an alternative progestogen
• Women with suspected or confirmed endometrial hyperplasia who have been on progesterone: the regimen has already failed endometrial protection; a gynecologist needs to assess before restarting any progestogen
• Pregnant women: oral micronized progesterone HRT is not appropriate; a separate obstetric consultation is needed

Practical Steps When Your Progesterone Regimen Is Not Working

1. Confirm whether you are on brand (Prometrium) or a compounded product.
2. If compounded, ask your pharmacy for their most recent third-party potency certificate for your specific batch.
3. Verify you are taking it at bedtime with food.
4. Confirm the dose matches your clinical goal (100 mg continuous, or 200 mg sequential for at least 12 days).
5. Review your full medication and supplement list for CYP3A4 inducers.
6. If you have a peanut allergy, confirm you are not on Prometrium.
7. Report any unexpected vaginal bleeding to your clinician before adjusting progesterone on your own.
8. If breakthrough bleeding persists after correcting the above, your clinician may order an endometrial biopsy and consider switching routes (oral to vaginal, or increasing sequential duration to 14 days).

A serum progesterone level drawn 2-3 hours after an oral dose can confirm absorption. Levels below 1 ng/mL in that window suggest very poor absorption and support a route change rather than a dose increase.